Literature DB >> 17047166

Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1.

Masahiro Tsuda1, Tomohiro Terada, Jun-ichi Asaka, Miki Ueba, Toshiya Katsura, Ken-ichi Inui.   

Abstract

Recently, we have isolated the rat (r) H(+)/organic cation antiporter multidrug and toxin extrusion 1 (MATE1) and reported its tissue distribution and transport characteristics. Functional characterization suggested that an oppositely directed H(+) gradient serves as a driving force for the transport of a prototypical organic cation, tetraethylammonium, by MATE1, but there is no direct evidence to prove this. In the present study, therefore, we elucidated the driving force of tetraethylammonium transport via rMATE1 using plasma membrane vesicles isolated from HEK293 cells stably expressing rMATE1 (HEK-rMATE1 cells). A 70-kDa rMATE1 protein was confirmed to exist in HEK-rMATE1 cells, and the transport of various organic cations including [(14)C]tetraethylammonium was stimulated in intracellular acidified HEK-rMATE1 cells but not mock cells. The transport of [(14)C]tetraethylammonium in membrane vesicles from HEK-rMATE1 cells exhibited the overshoot phenomenon only when there was an outwardly directed H(+) gradient, as observed in rat renal brush-border membrane vesicles. The overshoot phenomenon was not observed in the vesicles from mock cells. The stimulated [(14)C]tetraethylammonium uptake by an H(+) gradient [intravesicular H(+) concentration ([H(+)](in)) > extravesicular H(+) concentration ([H(+)](out))] was significantly reduced in the presence of a protonophore, carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP). [(14)C]tetraethylammonium uptake was not changed in the presence of valinomycin-induced membrane potential. These findings definitively indicate that an oppositely directed H(+) gradient serves as a driving force of tetraethylammonium transport via rMATE1, and this is the first demonstration to identify the driving force of the MATE family. The present experimental strategy is very useful in identifying the driving force of cloned transporters whose driving force has not been evaluated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047166     DOI: 10.1152/ajprenal.00312.2006

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  21 in total

1.  Structural basis for the drug extrusion mechanism by a MATE multidrug transporter.

Authors:  Yoshiki Tanaka; Christopher J Hipolito; Andrés D Maturana; Koichi Ito; Teruo Kuroda; Takashi Higuchi; Takayuki Katoh; Hideaki E Kato; Motoyuki Hattori; Kaoru Kumazaki; Tomoya Tsukazaki; Ryuichiro Ishitani; Hiroaki Suga; Osamu Nureki
Journal:  Nature       Date:  2013-03-27       Impact factor: 49.962

2.  Role of ABC and Solute Carrier Transporters in the Placental Transport of Lamivudine.

Authors:  Martina Ceckova; Josef Reznicek; Zuzana Ptackova; Lukas Cerveny; Fabian Müller; Marian Kacerovsky; Martin F Fromm; Jocelyn D Glazier; Frantisek Staud
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Interaction of H+ with the extracellular and intracellular aspects of hMATE1.

Authors:  Yodying Dangprapai; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-25

4.  Effects of metabolic acidosis on expression levels of renal drug transporters.

Authors:  Arong Gaowa; Hideyuki Motohashi; Toshiya Katsura; Ken-ichi Inui
Journal:  Pharm Res       Date:  2010-12-15       Impact factor: 4.200

Review 5.  Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Authors:  Atsushi Yonezawa; Ken-ichi Inui
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.

Authors:  J König; O Zolk; K Singer; C Hoffmann; M F Fromm
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 7.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

8.  Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Hélène Chapy; Pascal André; Maria Smirnova; Marcel Debray; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2012-12-05       Impact factor: 4.009

Review 9.  Polymorphic transporters and platinum pharmacodynamics.

Authors:  Jason A Sprowl; Rachel A Ness; Alex Sparreboom
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-18       Impact factor: 3.614

10.  Mechanisms for Two-Step Proton Transfer Reactions in the Outward-Facing Form of MATE Transporter.

Authors:  Wataru Nishima; Wataru Mizukami; Yoshiki Tanaka; Ryuichiro Ishitani; Osamu Nureki; Yuji Sugita
Journal:  Biophys J       Date:  2016-03-29       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.